5-56815617-C-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_005921.2(MAP3K1):āc.44C>Gā(p.Pro15Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,312,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005921.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000119 AC: 18AN: 151212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000426 AC: 1AN: 23490Hom.: 0 AF XY: 0.0000681 AC XY: 1AN XY: 14684
GnomAD4 exome AF: 0.000120 AC: 139AN: 1160900Hom.: 0 Cov.: 31 AF XY: 0.000126 AC XY: 71AN XY: 563282
GnomAD4 genome AF: 0.000119 AC: 18AN: 151212Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 73862
ClinVar
Submissions by phenotype
46,XY sex reversal 6 Uncertain:1Benign:1
- -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Inborn genetic diseases Uncertain:1
The c.44C>G (p.P15R) alteration is located in exon 1 (coding exon 1) of the MAP3K1 gene. This alteration results from a C to G substitution at nucleotide position 44, causing the proline (P) at amino acid position 15 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at